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Phylogenetic analysis of the ketosynthase (KS) gene sequences of marine sponge-derived Salinispora strains
of actinobacteria indicated that the polyketide synthase (PKS) gene sequence most closely related to that of
Salinispora was the rifamycin B synthase of Amycolatopsis mediterranei. This result was not expected from
taxonomic species tree phylogenetics using 16S rRNA sequences. From the PKS sequence data generated from
our sponge-derived Salinispora strains, we predicted that such strains might synthesize rifamycin-like com-
pounds. Liquid chromatography-tandem mass spectrometry (LC/MS/MS) analysis was applied to one sponge-
derived Salinispora strain to test the hypothesis of rifamycin synthesis. The analysis reported here demon-
strates that this Salinispora isolate does produce compounds of the rifamycin class, including rifamycin B and
rifamycin SV. A rifamycin-specific KS primer set was designed, and that primer set increased the number of
rifamycin-positive strains detected by PCR screening relative to the number detectable using a conserved
KS-specific set. Thus, the Salinispora group of actinobacteria represents a potential new source of rifamycins
outside the genus Amycolatopsis and the first recorded source of rifamycins from marine bacteria.
Rifamycins, a group of antibiotics of the ansamycin family
(3, 20), are clinically important antibacterial agents active
against gram-positive bacteria. Several semisynthetic rifamycin
variants (e.g., rifampin) have been used clinically for the treat-
ment of tuberculosis and other bacterial infections, but resis-
tance threatens their effectiveness (17). Rifamycins are known
to be produced by the soil actinobacterial species Amycolatopsis
mediterranei, and rifamycin synthesis has been most intensively
studied in this species (2, 15, 16). The gene cluster for the
synthesis of rifamycin B, a compound forming the basis for all
other rifamycins, has been characterized only in A. mediterranei
(2, 15). Five polyketide synthase subunits (RifA to RifE) pro-
duce rifamycin B using 3-amino-5-hydroxybenzoic acid as a
starting point, and then RifF terminates the chain elongation
to produce free rifamycin B (20). Rifamycin B is processed
further by either natural modification enzymes or artificial
semisynthetic protocols to produce biologically active rifamy-
cins (Fig. 1). Widening the horizon of available rifamycin-
producing genera of actinobacteria beyond known rifamycin
producers could provide considerable assistance to efforts to
engineer new rifamycins via genetic recombination by taking
advantage of the full diversity of the sequence space of rifa-
mycin-synthetic genes (13). We have been able to show that
rifamycin-synthesizing actinobacteria are indeed found in a
species other than A. mediterranei, and to do this, we have used
a new approach applying phylogenetic analysis based on
polyketide synthase genes to the prediction of synthesis of
polyketide antibiotics in a particular chemical class.
New actinobacteria with biopharmaceutical potential have
been increasingly isolated from marine habitats (6, 7, 9, 12).
We have previously isolated and described Salinispora strains
derived from the marine sponge Pseudoceratina clavata (7),
members of a genus previously observed only in marine sedi-
ments and formally described recently (10, 12). These strains
display antibiotic activity and, significantly, -ketosynthase
(KS) gene fragments, indicating the existence of a polyketide
synthase (PKS) gene cluster (7). The Salinispora group, as a
relatively newly discovered group of Actinobacteria, is one with
great applied potential, and its properties and products are
only beginning to be explored. Members of this group have
been found in habitats as diverse as marine sediments and
marine sponges. Its full range of taxonomic diversity is un-
known, but at least two species have been identified.
Phylogenetic analysis of KS gene sequences from marine-
sponge-derived Salinispora strains indicated that the polyketide
synthase gene sequence most closely related to that of Salini-
spora was the rifamycin B synthase of A. mediterranei, a result
not expected from taxonomic phylogenetics using 16S rRNA
sequences. The closest relatives to the Salinispora strains on
the basis of 16S rRNA sequence analysis were members of the
genus Micromonospora. From the KS gene sequence data gen-
erated from our sponge-derived Salinispora strains, we pre-
dicted that such strains might synthesize rifamycin-like com-
pounds on the basis of the relationship of their KS genes to
those of Amycolatopsis. Liquid chromatography-tandem mass
spectrometry (LC/MS/MS) analysis was applied to one sponge-
derived Salinispora strain to test the hypothesis of rifamycin
synthesis. The analysis demonstrated that this Salinispora was
indeed able to produce compounds of the rifamycin class,
including rifamycin B and rifamycin SV. The availability of the
KS gene sequences for both Salinispora and A. mediterranei
made the design of a rifamycin-specific PCR primer set possi-
ble, and PCR using this primer set was applied to screening of
new Salinispora strains for KS genes associated with rifamycin
synthesis. Chemical analysis confirmed that strains positive for
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PCR with rifamycin-specific primers were also positive for
synthesis of rifamycins. Using the rifamycin-specific primer set
also increased the number of PKS-synthesizing strains detected
by such PCR screening beyond those detectable with a simple
KS-specific primer set.
Rifamycins, previously known to be produced only by soil
actinobacteria, have now been found to also be produced by
marine bacteria—Salinispora isolated from the marine sponge
Pseudoceratina clavata. Significantly, Salinispora forms a poten-
tial new source of rifamycins and polyketide synthesis gene
clusters specific to rifamycin synthesis outside the genus Amy-
colatopsis. This opens the way to insights from comparative
genomic analysis of rifamycin synthesis gene clusters and, for
the first time, to gene recombinational engineering. Such en-
gineering can exploit the sequence and operon diversity hidden
in rifamycin gene clusters from diverse bacteria (5).
MATERIALS AND METHODS
Bacterial strains and culture. Salinispora strains were isolated from the Great
Barrier Reef sponge Pseudoceratina clavata and cultured for maintenance pur-
poses on starch-yeast extract-peptone (SYP) medium with artificial seawater
(ASW) at 28°C (7). Amycolatopsis mediterranei (Australian Collection of Micro-
organisms no. 2548) was maintained on starch-yeast extract-peptone medium
without ASW at 28°C.
Phylogenetic analysis. Amino acid sequences corresponding to ketosynthase
used in this analysis had been retrieved from marine Salinispora strains using
degenerate PCR and sequencing as described in a previous study from our
laboratory (7). The GenBank accession numbers resulting from that study are
AAT68460 to AAT68464. Using the PHI and PSI-BLAST algorithms at NCBI
with default parameters, the Salinispora putative KS amino acid sequences were
used as queries in a search of the nonredundant database for closely related
reference sequences (1). The resulting reference sequences (all type I KS se-
quences) were aligned with the Salinispora sequences using the ClustalX (version
1.81) program after all sequences had been manually edited so that they were
flanked by conserved sequences ([M/V]DPQQR and HGTGT) (18). A maximum
likelihood tree was generated with the Dayhoff PAM model using PROML
within the PHYLIP package (4). One thousand bootstrap resamplings of neighbor-
joining (PROTDIST and NEIGHBOR), parsimony (PROTPARS), and maxi-
mum likelihood (PROML) analyses were performed using SEQBOOT and
CONSENSE within PHYLIP. A type II KS (ActI of Streptomyces coelicolor) was
used as the outgroup in that analysis.
Preparation of extracts for LC/MS/MS analysis. Salinispora M403 was cul-
tured on SYP agar medium with ASW, and A. mediterranei was cultured on SYP
agar medium without ASW at 28°C for 4 weeks. The mycelial cell mass was
harvested from the medium by scraping using a glass slide, and the mass was
weighed. Absolute ethanol was added in sufficient volume to submerge all the
mycelia. The mycelium and ethanol mixture was incubated for 90 min at room
temperature with rotation. The liquid phase was clarified by centrifugation, and
then the extraction of the cell pellet with ethanol was repeated. The combined
extracts were filtered using a 0.22-m-pore-size filter and then stored at 20°C.
LC/MS/MS analysis of extracts. Rifamycin SV sodium salt was purchased
from Sigma (St. Louis, MO), and rifamycin B was donated by Lupin Ltd (Tara-
pur, Maharashtra, India). All solvents used were high-performance liquid chro-
matography (HPLC) grade. Ethanol extracts were evaporated using a freeze
drier and then reconstituted initially with methanol and then with water, result-
ing in a final composition of 45% (vol/vol) methanol-water and representing a
10-fold concentration of the original extracts. The samples were filtered through
0.22-m filters, and 100-l aliquots were injected into the column using an
autosampler. The separation was carried out using a binary solvent gradient
consisting of a 0.1% (wt/vol) aqueous solution of ammonium acetate (A) and a
0.1% (wt/vol) acetonitrile solution of ammonium acetate (B) delivered (200 l
min1) by an Agilent Binary HPLC system with a Cogent Aclarity-C18 (2.0- by
50-mm; 5-m) HPLC column (Microsolv Technology Corporation, Long
Branch, NJ). The separated compounds were detected and analyzed using an
API 3000 tandem mass spectrometer equipped with a turbo ion spray interface
and supported by Analyst 1.4 software (Applied Biosystems, Foster City, CA).
The mass spectrometer was operated in Q1-total ion current negative-ion mode
within the range 200 to 800 atomac mass units. The fragmentation pattern of
each molecular ion was obtained by Q3-MS2 negative-ion mode within the 200-
to 800-atomic-mass-unit range. The fragmentation of ion 755 (rifamycin B) was
monitored for the first 3.2 min of the chromatographic run, and that of ion 696.8
(rifamycin SV) was monitored for the remainder of the run.
Rifamycin ketosynthase-specific primer set design and amplification. A rifa-
mycin-specific degenerate primer set (Riff and Rifr) was designed using an
alignment of KS sequences of A. mediterranei, Salinispora strains, and other
reference actinobacteria. A typical 50-l reaction mixture contained 180 ng to 1.5
g of genomic DNA, 200 ng of Riff (5-RTGGAYCCBCAGCAGCGG-3) for-
ward primer, 200 ng of Rifr (5-RCGCTCSCGMGCCACCGA-3) reverse
primer, 0.2 mM of each deoxynucleoside triphosphate, 5% (vol/vol) dimethyl
sulfoxide, and 2.5 U of AmpliTaq Gold (Roche, CA). The cycling consisted of
94°C for 5 min (activation of AmpliTaq), followed by 30 cycles of denaturation
(94°C for 1 min), annealing (56°C for 1 min), and extension (72°C for 1 min), and
then amplification was terminated with a final extension (72°C for 10 min). Bands
of the expected size (ca. 510 bp) were excised, and then DNA was extracted using
NucleoSpin Extract II kits (BD Biosciences, CA). The nucleotide sequences were
determined using ABI BigDye terminator version 3.1 with ABI 3730xl sequenc-
ing platforms. The resulting sequences were matched with the GenBank data-
base using BLASTX with default parameters (1).
RESULTS
Phylogenetic analysis. The NCBI protein database was
searched via PHI and PSI-BLAST using the sequences re-
trieved from Salinispora by PCR with KS-specific primer sets as
queries. The top matched sequences were type I KS domains
of rifamycin B synthase of A. mediterranei (more than 80%
identity and 90% similarity), followed by KS domains from the
genus Streptomyces. The Salinispora homologues shared amino
acid sequence motifs characteristic of KS domains that were
derived from examination of multiple alignments of type I KS
domains. These motifs included the KS consensus amino acid
sequences (M/V)DPQQR and TXCSSSLV (including the ac-
tive-site cysteine) and E(A/G)HGTGT (including the active-
site histidine). A rifamycin synthase-specific pattern (VARER)
was detected within the KS sequences of both rifamycin and
Salinispora KSs, including the unique amino acid valine at
position 162 (Fig. 2). In phylogenetic analysis, Salinispora KS
FIG. 1. Chemical structures of the rifamycins; the naphthofuran
fragment expected at m/z 273 is indicated by the naphthofuran system
outline in each case.
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sequences clustered with the KS domains of the rifamycin B
synthesis PKS from A. mediterranei, as supported by significant
(99/85/89% [neighbor-joining/parsimony/maximum likelihood])
bootstrap values. Salinispora KS sequences and the rifamycin
KS sequences were members of a larger cluster with other
actinobacterial KS sequences, a cluster supported by 87/98/
94% bootstrap values (Fig. 3). The genus Micromonospora is
the group most closely related to Salinispora according to the
16S rRNA sequences, but this relationship was not found in
our analysis of KS sequences. The KS tree did not show any
significant relation between Salinispora KSs and Micromonos-
pora KS (Myc A1). The KS amino acid sequence tree topology,
however, was consistent with 16S rRNA trees at a coarser level,
since phylum-level groups of Actinobacteria, Firmicutes (low-
GC percentage gram-positive bacteria), and Cyanobacteria
could be distinguished in both cases. The Salinispora KS gene
amino acid sequence displayed 90% similarity to the amino
acid sequence of the RifB gene of A. mediterranei but only 74%
amino acid sequence similarity to that of the KS gene of Mi-
cromonospora. This is consistent with the phylogenetic analysis
of KS gene amino acid sequences.
LC/MS/MS data analysis. The chromatograms monitored
using total ion current mode showed that both the Salinispora
M403 and A. mediterranei extracts contained peaks that eluted
with retention times similar to those of the standard com-
pounds rifamycin B and SV. These peaks were absent from the
blank extracts. The electrospray negative-ion spectrum of each
peak resembled those of the standard rifamycins B and SV
(data not shown), confirming the identities of the peaks in
Salinispora M403 and A. mediterranei extracts. To further ex-
plore the identities of the peaks present in extracts, the sample
and standard chromatograms were monitored using MS2
(fragmentation using the third quadrupole). The fragmenta-
tion of the molecular ion 755 (rifamycin B) was monitored for
the first 3.2 min of the run, and that of the molecular ion 696.8
(rifamycin SV) was monitored for the remainder of the chro-
matographic run. The chromatograms and the MS2 spectra of
the rifamycin B and SV standards and those of the samples
(Fig. 4 and 5) displayed marked similarity, further confirming
the identities of rifamycins B and SV in the samples. The
presence of an m/z 273 naphthofuran fragment, which is con-
sidered the structurally most useful signature fragment of rif-
amycins (19), provides conclusive evidence for the identifica-
tion of rifamycins in Salinispora M403 extracts (Fig. 5). The
structure of this fragment is shown in Fig. 1. The fragmentation of
rifamycin B (m/z 755) occurs initially by the loss of an acetate
group to produce rifamycin SV (m/z 696.8) and then subsequently
by fragmentation of the ansa group to produce the m/z 273 frag-
ment, which is observed for both rifamycin B and SV. The obser-
vation that the HPLC mass chromatograms and the mass spectra
(Fig. 5) obtained for the extracts of A. mediterranei, which is
known to produce rifamycins B and SV (14, 16), resemble those
of Salinispora M403 extracts (Fig. 5) further confirms the pres-
ence of these compounds in Salinispora.
Rifamycin-specific primers. Comparison of rifamycin KS
gene sequences between A. mediterranei and Salinispora strains
made the design of rifamycin-specific primers possible (Fig. 2).
The rifamycin-specific primer set discriminatingly amplified rifa-
mycin KS genes from A. mediterranei and Salinispora strains,
but not from reference strains. The reference strains included
strains producing PKS, but not rifamycin, and non-Salinispora
sponge isolates in which KS genes had been detected using a
primer set designed to be specific only for ketosynthase in
general. The rifamycin-specific primer set increased the num-
ber of PKS-synthesizing strains detected by PCR screening to
9 out of 10 Salinispora isolates, while only five strains were
detected within this set of 10 isolates when the general KS
primer set was used (7).
DISCUSSION
We have demonstrated by chemical analysis that a marine-
sponge-derived actinobacterium, Salinispora M403, can pro-
duce both rifamycin B and rifamycin SV. This is consistent with
our evidence that five strains of these Salinispora isolates pos-
sess genes for the ketosynthase enzyme, which forms the key
part of the polyketide synthase enzyme complex. This is also
consistent with our finding that these genes are most closely
related to those of A. mediterranei, which is a known producer
of rifamycins B and SV. While they are most closely related to
rifamycin KS genes of A. mediterranei, the KS genes of Salinispora
strains are not identical, suggesting potential genetic diversity
among rifamycin synthesis genes from different genera. Members
of the Salinispora group of marine actinobacteria thus consti-
tute a potential new source of antibiotics and other biophar-
maceutically active compounds in the rifamycin class and also
a possible source of new rifamycin synthesis genes. The only
known source of rifamycins supported by published evidence
for rifamycin production is A. mediterranei (14, 16), and this
species has been subjected to considerable genetic analysis of
its polyketide synthase gene cluster (2, 15). Other sources have
been reported in documentation accompanying culture collec-
tion databases (e.g., within cultures held in the American Type
Culture Collection, Streptomyces albovinaceus ATCC 12951,
Micromonospora lacustris ATCC 21974, ATCC 21975, and Mi-
cromonospora chalcea ATCC 21994, all without any supporting
chemical data accompanying annotations). Except for Mi-
cromonospora lacustris ATCC 21975 (8), 16S rRNA sequence
data do not appear to have been released for these culture
collection strains reported to produce rifamycins, so that their
taxonomic status remains uncertain within the context of mod-
ern molecular phylogenetics of actinobacteria. Salinispora is a
taxonomically well-defined genus level group, at least one
member of which produces rifamycins as confirmed by chem-
ical analysis and supported by gene sequence phylogenetics. It
thus provides a second model, in addition to the existing A.
mediterranei model, for the study of rifamycin production and
its genomics and genetics, which may prove useful for compar-
ative purposes (13). The expansion of rifamycin polyketide
synthase gene sequences by the inclusion of Salinispora, as well
as Amycolatopsis, has also made a rifamycin-specific primer set
possible. We found that application of these high-specificity
primers could increase the detection rate of PCR screening for
certain KS genes. However, even these highly specific primers
are not free from PCR bias, because when we repeated the
chemical analysis of the remaining Salinispora strains, we de-
tected production of rifamycins from all 10 Salinispora strains.
Thus, the Salinispora group of actinobacteria represents the
first recorded source of rifamycins from marine bacteria. To
discover this source, we used an approach of applying phylo-
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FIG. 3. Maximum likelihood tree generated using amino acid sequences of KS from marine sponge Salinispora strains (boldface) and reference organisms
for type I KS. Significant bootstrap values (50%) are indicated at each node in the following order from top to bottom: neighbor-joining, parsimony, and
maximum likelihood. The scale bar represents 0.1 amino acid substitution per site. Streptomyces coelicolor ActI (a type II KS) was used as the outgroup.
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FIG. 4. Chromatograms and fragmentation patterns of standard compounds rifamycin B and rifamycin SV monitored using MS2 negative-ion
mode. (A) Chromatogram of rifamycin B. (B) Fragmentation pattern of the rifamycin B peak. (C) Chromatogram of rifamycin SV and rifamycin
S (a breakdown product of rifamycin SV), which is apparent at 6.93 min. (D) Fragmentation pattern of the rifamycin SV peak.
2123
 o
n
 N
ovem
ber 12, 2015 by University of Queensland Library
http://aem
.asm
.org/
D
ow
nloaded from
 
FIG. 5. Chromatograms and fragmentation patterns of A. mediterranei and Salinispora M403 extracts monitored using MS2 negative-ion mode.
(A and D) Chromatograms of A. mediterranei (A) and Salinispora M403 (D) extracts. (B and E) Fragmentation patterns of A. mediterranei (B) and
Salinispora M403 (E) rifamycin B peaks. (C and F) Fragmentation patterns of A. mediterranei (C) and Salinispora M403 (F) rifamycin SV peaks.
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genetic analysis based on polyketide synthase genes to the
prediction of synthesis of polyketide antibiotics in a particular
chemical class. Such molecular prediction could conceivably
preclude the need for time-consuming nontargeted chemical
assay. Significantly for biotechnology, the discovery of rifamy-
cin synthesis by Salinispora strains implies that they are a po-
tential new source, outside the genus Amycolatopsis, of rifamy-
cins and of polyketide synthesis gene clusters specific to
rifamycin synthesis. Comparative genomic analysis of rifamycin
synthesis gene clusters using strains from the two distinct genus
level taxa known to harbor strains producing rifamycins will
now be possible. The resulting bank of variation within rifa-
mycin genes may become available for gene recombinatorial
engineering and design of synthetic genes on the basis of con-
served rifamycin-associated motifs (11). With the availability of
new PKS gene clusters and regulatory genes associated with
rifamycin synthesis from Salinispora, an advantage could be
derived from the study of the full diversity of the sequence
space of rifamycin-synthetic genes and associated regulatory
genes. If the efficiency of rifamycin production varies among
strains, as occurs with synthesis of erythromycin (13), then the
availability from diverse bacteria of gene clusters associated
with the synthesis and regulation of rifamycin could conceiv-
ably be useful for designing increased yields from rifamycin-
synthesizing strains. The highly conserved but nonidentical
genes for the synthesis of antibiotics in the same rifamycin class
could also contribute to research programs aiming to produce
novel recombinatorial antibiotics (13).
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